← Who reports today · Health Care
How Intuitive Surgical (ISRG) makes money: Q3 2026 revenue breakdown
Net income attributable to Intuitive Surgical, Inc.
$523M
down 25.8% y/y
Total revenue
$3,049M
up 21.7% y/y
Income from operations
$593M
down 22.0% y/y
Next report
~ Jan 21
not announced yet
The quarter in brief
Revenue rose 22% to $3.05 billion, but operating income fell to $593 million from $760 million. GAAP net income fell 26% to $523 million and diluted EPS fell to $1.49 from $1.95.
Key growth driver: Instruments and accessories — the fastest-growing revenue line: $1,797, +18% y/y. · by the Q3 2026 report
- Total revenue +21.7% — growth in procedure volume, higher operating lease revenue and a larger installed base of systems
Source
«Third quarter 2026 revenue was $3.05 billion, an increase of 22% compared with $2.51 billion in the third quarter of 2025. The higher third quarter revenue was driven by growth in procedure volume, higher operating lease revenue, and an increase in the installed base of systems.»
press release, 8-K
How does Intuitive Surgical make money?
Intuitive Surgical brought in $3.05 billion of revenue in Q3 2026, up 21.7% year over year. The largest source was Instruments and accessories: $1.80 billion, or 59% of the total, followed by Systems ($769M, 25%) and Services ($482M, 16%). Net income for the quarter was $523 million, down 25.8% year over year.
Revenue by source, Q3 2026
- Instruments and accessories$1.80B · 59% · +18.3%
- Systems$769M · 25% · +30.3%
- Services$482M · 16% · +21.8%
Shares of $3.05B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.
All figures in $M.
| Line item | Amount and change |
|---|---|
| Instruments and accessories | $1,797 · +18.3% |
| Systems | $769 · +30.3% |
| Services | $482 · +21.8% |
| Total revenue | $3,049 · +21.7% |
| Cost of revenue: Product | $798 · +14.1% |
| Cost of revenue: Service | $167 · +16.3% |
| Gross profit | $2,084 · +25.4% · 68.4% margin |
| Selling, general, and administrative | $1,083 · +89.0% |
| Research and development | $408 · +24.0% |
| Income from operations | $593 · −22.0% · 19.4% margin |
| Interest and other income, net | $75.8 · −20.6% |
| Income before taxes | $668 · −21.8% |
| Income tax expense | $144 · −1.4% · 21.5% effective rate |
| Net income attributable to noncontrolling interest in joint venture | $1.6 · −66.7% |
| Net income attributable to Intuitive Surgical, Inc. | $523 · −25.8% · $1.49/sh · 17.1% margin |
Verdict: Revenue rose 22% to $3.05 billion, but operating income fell to $593 million from $760 million. GAAP net income fell 26% to $523 million and diluted EPS fell to $1.49 from $1.95.
For 2026 the company expects da Vinci procedure growth of about 14% to 15%, non-GAAP gross margin of 68.7% to 69.3% and non-GAAP operating expense growth of 11% to 13%. The company repurchased 7.8 million shares for $2.94 billion in the quarter. Cash, cash equivalents and investments fell by $1.83 billion to $6.80 billion.
Source and notation
Source: Intuitive Surgical press release, 8-K EX-99.1 of 10/20/2026 (SEC EDGAR).
Open as an image: Intuitive Surgical (ISRG), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “Intuitive Surgical (ISRG) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/isrg. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/isrg"><img src="https://whoreportstoday.com/t/isrg/img/intuitive-surgical-isrg-earnings-sankey.png" alt="Intuitive Surgical (ISRG) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/isrg">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/isrg/img/intuitive-surgical-isrg-earnings-sankey.png
<a href="https://whoreportstoday.com/t/isrg">Intuitive Surgical (ISRG) Q3 2026 earnings chart (Who Reports Today)</a>
The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- The antitrust settlement cost $347 million after tax, or $0.99 per diluted share.
- Systems revenue grew 30% to $769.1 million; instruments and accessories rose 18% to $1,797.4 million.
- Operating margin fell to 19.4% from 30.3%, while R&D grew 24% to $408.3 million.
- Interest and other income declined to $75.8 million from $95.5 million, and the effective tax rate rose to 21.5% from 17.1%.
- Diluted shares fell to 351.6 million from 361.8 million.
What distorts the picture in this report and what to watch beyond the headlines.
Who runs the company now
- David J. RosaChief Executive Officer [1]
- Jamie E. SamathExecutive Vice President and Chief Financial Officer [2]
As of 11/18/2026, per the company’s SEC filings: signatures on the latest report and leadership-change filings.
Positions and previous jobs: the company’s SEC filings. Spotted an error, or is this you and you’d like it corrected or removed? Contact us
Where they worked before
- Intuitivesince 2011
- Chief Executive Officersince 2025
- President2023–2025
- Chief Strategy and Growth Officer2022–2023
- EVP, Chief Business Officer2019–2022
- EVP, Chief Commercial Officer2015–2019
- EVP, Chief Scientific Officer2014–2015
- SVP, Emerging Procedures and Technology and SVP, Scientific Affairs2011–2014
- Kardiumsince 2018Director
- Arterys2017–2022Director
- Acuson1989–1996Mechanical Design Engineer
Source: SEC EDGAR: DEF 14A proxy statement, 2026-03-13 · as of 10/21/2026
- KLAsince 2025Director
- AtmelVice President Finance, Corporate Controller and Principal Accounting Officer
- National SemiconductorVarious finance roles
Source: SEC EDGAR: DEF 14A proxy statement, 2026-03-13 · as of 10/21/2026
How this is compiled
Who runs the company now comes from primary sources only: for US and Canadian companies, the CEO and CFO signatures on the latest SEC report, and a separate board chair from the proxy materials; for Russian and Kazakh issuers, the company website and its disclosures. We recheck weekly; if a name can’t be confirmed, or a leadership-change filing came out after the report, we don’t show it until it’s reviewed. Previous jobs are only what the company itself disclosed about its current leaders (the past five years of business experience in the annual report and proxy materials): employer, position and years, restated as facts, with no age, education or other personal details. If the company doesn’t disclose it, we don’t look elsewhere. Anything more than 400 days past its last check is hidden. These are public business facts from disclosures, shown to tell investors who runs the company (our legitimate interest); if this is you and you object, contact us via the link above and we’ll remove it.
Sources · 2
- SEC EDGAR: 10-Q 2026-10-21 · SEC EDGAR · 11/18/2026
- SEC EDGAR: 10-Q 2026-10-21 · SEC EDGAR · 11/18/2026
Intuitive Surgical, Inc. is an American biotechnology company that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. · Text: Wikipedia, CC BY-SA 4.0, abridged
The company is part of the Nasdaq-100, S&P 100 and S&P 500. As of 31 December 2021, Intuitive Surgical had an installed base of 6,730 da Vinci Surgical Systems, including 4,139 in the U.S., 1,199 in Europe, 1,050 in Asia, and 342 in the rest of the world.
Heads-up
- net income fell 26% y/y in Q3 2026
Net income for Q3 2026: $523M, −26% y/y. In the report's figures: costs grew faster than revenue: selling, general, and administrative +89% y/y. Based on the Q3 2026 report.
The company's report ↗Company reports
Company guidance
Same quarter a year ago (ended December 31, 2025): revenue $2.866B, EPS (GAAP) $2.19
How we calculate
Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.
ISRG earnings history: past report dates
| Oct 20, 2026 Tue | 4:05 pmafter market close | Sep 30, 2026 | $3.0B+22% y/y | $1.49−24% y/y |
| Jul 16, 2026 Thu | 4:05 pmafter market close | Jun 30, 2026 | $2.9B+19% y/y | $2.29+27% y/y |
| Apr 21, 2026 Tue | 4:09 pmafter market close | Mar 31, 2026 | $2.8B+23% y/y | $2.28+19% y/y |
| Jan 22, 2026 Thu | 4:05 pmafter market close | Dec 31, 2025 | ≈$2.9B+19% y/y | ≈$2.19+16% y/y |
| Oct 21, 2025 Tue | 4:03 pmafter market close | Sep 30, 2025 | $2.5B+23% y/y | $1.95+25% y/y |
| Jul 22, 2025 Tue | 4:03 pmafter market close | Jun 30, 2025 | $2.4B+21% y/y | $1.81+24% y/y |
| Apr 22, 2025 Tue | 4:03 pmafter market close | Mar 31, 2025 | $2.3B+19% y/y | $1.92+27% y/y |
| Jan 23, 2025 Thu | 4:03 pmafter market close | Dec 31, 2024 | ≈$2.4B+25% y/y | ≈$1.89+12% y/y |
| Oct 17, 2024 Thu | 4:02 pmafter market close | Sep 30, 2024 | $2.0B+17% y/y | $1.56+34% y/y |
| Jul 18, 2024 Thu | 4:03 pmafter market close | Jun 30, 2024 | $2.0B+14% y/y | $1.46+24% y/y |
| Apr 18, 2024 Thu | 4:04 pmafter market close | Mar 31, 2024 | $1.9B+11% y/y | $1.51+51% y/y |
| Jan 23, 2024 Tue | 4:02 pmafter market close | Dec 31, 2023 | ≈$1.9B+17% y/y | ≈$1.69+86% y/y |
| Oct 19, 2023 Thu | 4:04 pmafter market close | Sep 30, 2023 | $1.7B+12% y/y | $1.16+29% y/y |
| Jul 20, 2023 Thu | 4:00 pmafter market close | Jun 30, 2023 | $1.8B+15% y/y | $1.18+39% y/y |
| Apr 18, 2023 Tue | 4:01 pmafter market close | Mar 31, 2023 | $1.7B+14% y/y | $1.00+0% y/y |
| Jan 24, 2023 Tue | 4:01 pmafter market close | Dec 31, 2022 | ≈$1.7B+7% y/y | ≈$0.91−12% y/y |
Show all 16 reports since 2023Show fewer
How we count
Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.
Intuitive Surgical: 15-year financials
| 2025 | 10,065 | 2,946 | 2,856 | 2,491 |
| 2024 | 8,352 | 2,349 | 2,323 | 1,304 |
| 2023 | 7,124 | 1,767 | 1,798 | 750 |
| 2022 | 6,222 | 1,577 | 1,322 | 958 |
| 2021 | 5,710 | 1,821 | 1,705 | 1,750 |
| 2020 | 4,358 | 1,050 | 1,061 | 1,143 |
| 2019 | 4,479 | 1,375 | 1,379 | 1,173 |
| 2018 | 3,724 | 1,199 | 1,128 | 982 |
| 2017 | 3,138 | 1,063 | 671 | 953 |
| 2016 | 2,707 | 950 | 738 | 1,033 |
| 2015 | 2,384 | 740 | 589 | 725 |
| 2014 | 2,132 | 545 | 419 | 560 |
| 2013 | 2,265 | 853 | 671 | 775 |
| 2012 | 2,179 | 878 | 657 | 700 |
| 2011 | 1,757 | 695 | 495 | 595 |
$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.
How we calculate
Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.
Intuitive Surgical: 15-year balance sheet
| Year | Assets | Equity | Cash | Current assets | Current liabilities |
|---|---|---|---|---|---|
| 2025 | 20,459 | 17,824 | 3,368 | 9,780 | 2,006 |
| 2024 | 18,743 | 16,434 | 2,027 | 7,111 | 1,745 |
| 2023 | 15,442 | 13,308 | 2,750 | 7,888 | 1,659 |
| 2022 | 12,974 | 11,042 | 1,581 | 6,253 | 1,422 |
| 2021 | 13,555 | 11,901 | 1,291 | 5,845 | 1,150 |
| 2020 | 11,169 | 9,732 | 1,623 | 6,626 | 965 |
| 2019 | 9,733 | 8,264 | 1,168 | 4,663 | 1,030 |
| 2018 | 7,847 | 6,679 | 858 | 4,333 | 821 |
| 2017 | 5,777 | 4,779 | 648 | 2,809 | 663 |
| 2016 | 6,487 | 5,778 | 1,037 | 3,250 | 597 |
| 2015 | 4,907 | 4,320 | 715 | 2,196 | 492 |
| 2014 | 3,959 | 3,379 | 600 | 1,812 | 501 |
| 2013 | 3,950 | 3,501 | 782 | 1,932 | 381 |
| 2012 | 4,059 | 3,580 | 554 | 1,893 | 402 |
| 2011 | 3,063 | 2,646 | 466 | 1,466 | 321 |
$ millions, at fiscal year-end*.
* Sources
How we calculate
Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .
Cash flow
9 months ended 2026-09-30 · $M
| Line | This period | Year ago | Δ |
|---|---|---|---|
| Operating cash flowcash the business generated | 3,197 | 2,138 | +1,059 |
| · incl. stock-based comp (non-cash)share-based compensation | 632 | 585 | |
| Capexpurchases of property & equipment | −329 | −377 | +48.3 |
| Free cash flow ≈operating cash flow − capex | 2,868 | 1,761 | +1,107 |
| Investing activities, netcapex, acquisitions, securities | 957 | 875 | +81.5 |
| · incl. acquisitionsbusinesses net of cash acquired | −519 | −1.2 | −517 |
| Financing activities, netdebt, buybacks, dividends | −4,535 | −2,227 | −2,309 |
| · incl. buybacksrepurchases of common stock | −4,419 | −2,094 | −2,325 |
| · incl. dividends paid | — | 0 | |
| FX effect on cash | −3.5 | 0.5 | −4 |
| Net change in cash | −385 | 787 | −1,172 |
How to read the table
Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.
Shareholders’ equity at Sep 30, 2026: $16.0B (83% of total assets). Compare with other S&P 500 companies →
Corporate governance
2/2good
- Jun 2018Intuitive Surgical agreed to pay $42.5M to settle a shareholder class action — below the methodology's $50M threshold. sec.gov ↗
- Feb 2026Per the 2025 10-K, one class of shares; the notes list no pending shareholder disclosure suits or SEC cases. sec.gov ↗
1 more fact and scoring
How the company treats minority shareholders: 2 — well, 0 — systematically poorly.
- Dec 2025Diluted share count 2020→2025 +0.5%; SBC is 7.8% of revenue (XBRL 10-K). data.sec.gov ↗
Scoring: 2.0, no deductions = 2.0
- Share classes
- Single class of common stock (10-K cover).
- Dilution
- Diluted share count 2020→2025 +0.5%; SBC 7.8% of revenue (<10%); buybacks of $2.6B in 2022 and $2.3B in 2025.
- Disclosure
- 10-Ks and 10-Qs filed on time, audited US GAAP financials; no deduction.
- Dividends
- Pays no dividends and has not promised any — no deduction.
- Lawsuits & regulators
- The 2013 shareholder class action was settled in 2018 for $42.5M — below the $50M threshold, no deduction; the 10-K shows no new shareholder suits or SEC cases.
- Related parties
- No non-arm's-length related-party transactions.
How the score works · checked as of Oct 2026
Intuitive Surgical (ISRG) earnings: FAQ
How does Intuitive Surgical make money?
Intuitive Surgical brought in $3.05 billion of revenue in Q3 2026, up 21.7% year over year. The largest source was Instruments and accessories: $1.80 billion, or 59% of the total, followed by Systems ($769M, 25%) and Services ($482M, 16%). Net income for the quarter was $523 million, down 25.8% year over year.
When is ISRG's next earnings date?
We have not yet seen an announcement of the date from Intuitive Surgical (ISRG). Based on last year's report on Jan 22, 2026, the next report is expected around Jan 21, 2027.
What time does ISRG report earnings?
Intuitive Surgical usually reports after market close: its latest results release was filed with the SEC at 4:05 pm ET on Oct 20, 2026.
When did ISRG last report earnings?
Intuitive Surgical reported Q3 2026 results on Oct 20, 2026.
Where can I find Intuitive Surgical's financial statements?
On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to ISRG's filings; this page breaks the latest report down in a Sankey chart.
What was ISRG's net income in Q3 2026?
Intuitive Surgical reported net income of $523M for Q3 2026 (−25.8% year over year), under US GAAP.
How has Intuitive Surgical's revenue changed since 2011?
Per its 10-K filings, revenue grew 5.7x: $1,757M in 2011 and $10,065M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.
New to earnings reports? Start with how to read an earnings report.
Get it every Monday: who reports this week
Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.
More reports: JNJ · Q3 2026 · LH · Q3 2026 · LLY · Q3 2026 · MCK · Q1 FY2027 · MDT · Q1 2027 · MRK · Q3 2026 · MRNA · Q2 2026 · MTD · Q3 2026 · PFE · Q3 2026 · PODD · Q3 2026 · all reports